awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q26772723-4604088E-0F7D-46FD-823E-E802FC711989
Q26772723-4604088E-0F7D-46FD-823E-E802FC711989
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26772723-4604088E-0F7D-46FD-823E-E802FC711989
Inducing and Administering Tregs to Treat Human Disease
P2860
Q26772723-4604088E-0F7D-46FD-823E-E802FC711989
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26772723-4604088E-0F7D-46FD-823E-E802FC711989
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
fee0b075046ada9faf5b0ae9fa856bb631634288
P2860
Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trial.